Table 1.

Demographics, illness, and treatment characteristics by sex.

Characteristic	Total(n = 46)	Males(n = 33)	Females(n =13)
Age (y)	24.5 (4.4)	24.0 (3.9)	25.7 (5.4)
Duration Since Onset
0–3 mo	40 (87.0%)	29 (87.2%)	11 (84.6%)
3–6 mo	6 (13%)	4 (12.1%)	2 (15.4%)
Ethnicity (%)
White	40 (87.0%)	28 (84.8%)	12 (92.3%)
Asian	4 (8.8%)	4 (12.1%)	0
Chinese	1 (2.2%)	0	1 (7.7%)
Undeclared	1 (2.2%)	1 (3.0%)	0
Primary SCID Diagnosis
FEPa	25 (54.3%)	19 (57.6%)	6 (46.2%)
Schizophrenia	13 (28.3%)	10 (30.3%)	3 (23.1%)
Bipolar	4 (8.7%)	1 (3.0%)	3 (23.1%)
Acute psychotic episode	2 (4.3%)	2 (6.1%)	0
Non-organic	1 (2.2%)	0	1 (7.7%)
Other	1 (2.2%)	1 (3.0%)	0
Antipsychotic Treatment (%)
No medication	9 (17.8%)	7 (21.1%)	2 (15.4%)
Aripiprazole	4 (8.9%)	4 (12.1%)	0
Clozapine	3 (6.7%)	3 (9.1%)	0
Olanzapine	13 (28.9%)	9 (27.3%)	4 (30.8%)
Paliperidone	1 (2.2%)	1 (3.1%)	0
Quetiapine	13 (28.9%)	7 (21.2%)	6 (46.2%)
Risperidone	2 (4.4%)	1 (3.0%)	1 (7.7%)
Other	1 (2.2%)	1 (3.1%)	0
Antidepressant Treatment (%)
No medication	31 (67.4%)	25 (75.8%)	6 (46.2%)
Citalopram	1 (2.2%)	1 (3.0%)	0
Sertraline	2 (4.3%)	2 (6.1%)	0
Venlafaxine	4 (8.7%)	2 (6.1%)	2 (15.4%)
Fluoxetine	2 (4.3%)	0	2 (15.4%)
Other	5 (10.9%)	3 (9.1%)	3 (23.1%)

^aprovisional diagnosis of First Episode of Psychosis (FEP) (33).